STOCK TITAN

Aurora Spine Corp - ASAPF STOCK NEWS

Welcome to our dedicated news page for Aurora Spine (Ticker: ASAPF), a resource for investors and traders seeking the latest updates and insights on Aurora Spine.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aurora Spine's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aurora Spine's position in the market.

Rhea-AI Summary
Aurora Spine marks the completion of the second year of implantation of the world's first patient-bone-density matched interbody device, the DEXA-C. The innovative cervical interbody implants offer personalized solutions for anterior cervical discectomy with fusion procedures, revolutionizing spine surgery. Aurora also received IRB approval for a multicenter study of its DEXA-C Cervical Interbody System and obtained a new US patent for its DEXA Technology, paving the way for further advancements in orthopedic implants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Aurora Spine Corporation announces the issuance of its second United States Patent for DEXA Technology™ Patient-Matched Implant Technology. The DEXA Technology™ matches a patient’s bone density, promoting bone in-growth while maintaining the biomechanical structure and bone support. The company's DEXA Technology™ is part of its advanced portfolio representing the future of Spinal and Orthopedic implants. The technology has received the prestigious 2022 Best New Spine Technology Award and is well accepted by physicians. The patent strengthens the Company’s intellectual property portfolio significantly, allowing for the creation of implants that match the patient’s specific bone density based on a DEXA Scan/T-score. The technology is designed to overcome common osteoporosis challenges faced in traditional procedures, ultimately improving patient fusion rates and overall clinical outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Summary
Aurora Spine Corporation has announced the issuance of its United States Patent No: 11,832,853 entitled 'Hybrid Radiolucent Surgical Operating Tube'. The patent is for the Ghost Tube™, a translucent thermoplastic body with non-slipping titanium anchors designed to support surgical preparation tools without blocking x-ray visualization during surgery. This patent supports the recently launched SiLO TFX SI Fusion System and will allow the company to create new radiolucent tools for future product lines. Aurora Spine aims to continue being disruptive and innovative in delivering products and improving treatment options for better patient care and outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.92%
Tags
none
Rhea-AI Summary
Aurora Spine Corporation, a medical device manufacturer, will be participating in the NANS Annual Meeting to showcase its Sacroiliac Joint fusion products. The company will also present data from a recent clinical evaluation of its ZIP Interspinous Fixation device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Aurora Spine Corporation (ASG) to attend J.P. Morgan Healthcare Conference, President and CEO to present company's story to financial institutions and individuals
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Aurora Spine Corporation (ASG) Announces Conference Call to Discuss Q3 Fiscal 2023 Financial Results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.13%
Tags
Rhea-AI Summary
Aurora Spine completes private placement offering of units for gross proceeds of approximately CDN$1.9 million. The Company issued 6,445,939 Units at a price of CDN$0.30 per Unit. The proceeds will be used to fund increased working capital resulting from expected sales growth of new products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
-
Rhea-AI Summary
Aurora Spine announces full commercial release of SiLO TFX MIS Sacroiliac Joint Fixation Device system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.57%
Tags
none
-
Rhea-AI Summary
Aurora Spine Corp. to hold conference call for Q2 fiscal 2023 financial results on August 29, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
Aurora Spine Corp

OTC:ASAPF

ASAPF Rankings

ASAPF Stock Data

16.19M
52.25M
20.74%
0%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Canada
Toronto